| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of apoptotic cell clearance | 2.31e-05 | 8 | 156 | 3 | GO:2000427 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic cell clearance | 4.90e-05 | 10 | 156 | 3 | GO:2000425 | |
| GeneOntologyBiologicalProcess | positive regulation of termination of DNA-templated transcription | 5.68e-05 | 2 | 156 | 2 | GO:0060566 | |
| GeneOntologyBiologicalProcess | positive regulation of termination of RNA polymerase II transcription | 5.68e-05 | 2 | 156 | 2 | GO:1904595 | |
| GeneOntologyBiologicalProcess | negative regulation of zinc ion transport | 5.68e-05 | 2 | 156 | 2 | GO:0071582 | |
| GeneOntologyBiologicalProcess | regulation of zinc ion transmembrane transport | 5.68e-05 | 2 | 156 | 2 | GO:0071580 | |
| GeneOntologyBiologicalProcess | negative regulation of zinc ion transmembrane transport | 5.68e-05 | 2 | 156 | 2 | GO:0071583 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 3.05e-05 | 8 | 155 | 3 | IPR019565 | |
| Domain | Thiol-ester_cl | 3.05e-05 | 8 | 155 | 3 | PF10569 | |
| Domain | MacrogloblnA2_CS | 3.05e-05 | 8 | 155 | 3 | IPR019742 | |
| Domain | A2M | 6.45e-05 | 10 | 155 | 3 | PF00207 | |
| Domain | A2M_N_2 | 6.45e-05 | 10 | 155 | 3 | IPR011625 | |
| Domain | A2M_comp | 6.45e-05 | 10 | 155 | 3 | IPR011626 | |
| Domain | A2M_recep | 6.45e-05 | 10 | 155 | 3 | PF07677 | |
| Domain | A2M_comp | 6.45e-05 | 10 | 155 | 3 | PF07678 | |
| Domain | A2M_N | 6.45e-05 | 10 | 155 | 3 | PF01835 | |
| Domain | A2M_N | 6.45e-05 | 10 | 155 | 3 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 6.45e-05 | 10 | 155 | 3 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 6.45e-05 | 10 | 155 | 3 | PS00477 | |
| Domain | A2M_N_2 | 6.45e-05 | 10 | 155 | 3 | PF07703 | |
| Domain | Macroglobln_a2 | 6.45e-05 | 10 | 155 | 3 | IPR001599 | |
| Domain | Transferrin | 2.04e-04 | 3 | 155 | 2 | PF00405 | |
| Domain | Transferrin | 2.04e-04 | 3 | 155 | 2 | IPR016357 | |
| Domain | TRANSFERRIN_LIKE_4 | 2.04e-04 | 3 | 155 | 2 | PS51408 | |
| Domain | TRANSFERRIN_LIKE_1 | 2.04e-04 | 3 | 155 | 2 | PS00205 | |
| Domain | TRANSFERRIN_LIKE_2 | 2.04e-04 | 3 | 155 | 2 | PS00206 | |
| Domain | TRANSFERRIN_LIKE_3 | 2.04e-04 | 3 | 155 | 2 | PS00207 | |
| Domain | Transferrin_Fe_BS | 2.04e-04 | 3 | 155 | 2 | IPR018195 | |
| Domain | TR_FER | 2.04e-04 | 3 | 155 | 2 | SM00094 | |
| Domain | Transferrin-like_dom | 2.04e-04 | 3 | 155 | 2 | IPR001156 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 4.17e-04 | 18 | 155 | 3 | IPR008930 | |
| Domain | Anaphylatoxin_comp_syst | 6.73e-04 | 5 | 155 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 6.73e-04 | 5 | 155 | 2 | IPR001840 | |
| Domain | ANATO | 1.40e-03 | 7 | 155 | 2 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 1.40e-03 | 7 | 155 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 1.40e-03 | 7 | 155 | 2 | PS01177 | |
| Domain | ANATO | 1.40e-03 | 7 | 155 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 1.40e-03 | 7 | 155 | 2 | IPR000020 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 1.81e-05 | 7 | 115 | 3 | MM14685 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 2.87e-05 | 8 | 115 | 3 | M47872 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 2.87e-05 | 8 | 115 | 3 | M27031 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 8.32e-05 | 11 | 115 | 3 | M47874 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 8.32e-05 | 11 | 115 | 3 | MM1430 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 1.10e-04 | 12 | 115 | 3 | MM1368 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.43e-04 | 13 | 115 | 3 | M4732 | |
| Pathway | WP_13Q1212_COPY_NUMBER_VARIATION | 1.61e-04 | 34 | 115 | 4 | M48103 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 2.24e-04 | 15 | 115 | 3 | M7146 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 3.31e-04 | 17 | 115 | 3 | MM15944 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 3.31e-04 | 17 | 115 | 3 | MM1369 | |
| Pathway | WP_OXIDATIVE_DAMAGE_RESPONSE | 3.70e-04 | 42 | 115 | 4 | MM15945 | |
| Pubmed | FLNB TSHZ3 GEMIN5 MECOM ZDBF2 ZNF318 ANKHD1 MSTO1 DENND4C PRDM2 ARRB2 BUB1 AKAP1 TASOR | 1.16e-08 | 418 | 162 | 14 | 34709266 | |
| Pubmed | Genetic contributions of nonautoimmune SWR mice toward lupus nephritis. | 8.15e-08 | 24 | 162 | 5 | 11739537 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 3902621 | ||
| Pubmed | Paths reunited: Initiation of the classical and lectin pathways of complement activation. | 9.92e-08 | 3 | 162 | 3 | 19783065 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SP4 KLHL24 TSHZ3 STBD1 AFF2 TSG101 WNK1 ZNF469 ARRB2 SETBP1 BUB1 TNK2 ZFR | 1.29e-07 | 430 | 162 | 13 | 35044719 |
| Pubmed | Enhanced analysis of the mouse plasma proteome using cysteine-containing tryptic glycopeptides. | 3.42e-07 | 59 | 162 | 6 | 17330941 | |
| Pubmed | 3.94e-07 | 257 | 162 | 10 | 16335952 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 6190740 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 6088393 | ||
| Pubmed | The human complement system: assembly of the classical pathway C3 convertase. | 3.95e-07 | 4 | 162 | 3 | 6906228 | |
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 19302245 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 22689574 | ||
| Pubmed | Formation of high affinity C5 convertase of the classical pathway of complement. | 9.85e-07 | 5 | 162 | 3 | 12878586 | |
| Pubmed | RNF169 STBD1 TUT7 MECOM ZDBF2 NHLRC2 SLC30A1 WNK1 NDUFS1 DENND4C CEP350 AKAP1 USP1 TASOR ITPRIPL1 | 1.94e-06 | 733 | 162 | 15 | 34672954 | |
| Pubmed | SESTD1 FLNB SETX FN1 TUT7 GEMIN5 ZNF318 ANKHD1 THOC2 WNK1 ANKLE2 PRDM2 NEUROD1 CIPC DNA2 DDX21 TASOR QSOX2 | 3.40e-06 | 1084 | 162 | 18 | 11544199 | |
| Pubmed | HSPG2 FLNB FLNC FN1 WNK1 NDUFS1 PIK3C2A C1QTNF9 CIPC CCN2 AKAP1 USP1 | 4.12e-06 | 497 | 162 | 12 | 23414517 | |
| Pubmed | Molecular genetics of the human MHC complement gene cluster. | 5.46e-06 | 8 | 162 | 3 | 10072631 | |
| Pubmed | Mouse-human orthology relationships in an olfactory receptor gene cluster. | 5.46e-06 | 8 | 162 | 3 | 11170746 | |
| Pubmed | ZFP423 regulates early patterning and multiciliogenesis in the hindbrain choroid plexus. | 8.51e-06 | 28 | 162 | 4 | 33046507 | |
| Pubmed | Zbtb20 is essential for the specification of CA1 field identity in the developing hippocampus. | 1.47e-05 | 32 | 162 | 4 | 20308569 | |
| Pubmed | 1.59e-05 | 11 | 162 | 3 | 16769906 | ||
| Pubmed | Organizations and gene duplications of the human and mouse MHC complement gene clusters. | 1.59e-05 | 11 | 162 | 3 | 10686478 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 2.16e-05 | 2 | 162 | 2 | 16565498 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 15998580 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 2.16e-05 | 2 | 162 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 2.16e-05 | 2 | 162 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 2.16e-05 | 2 | 162 | 2 | 17645767 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 2.16e-05 | 2 | 162 | 2 | 27758680 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 22387014 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 2.16e-05 | 2 | 162 | 2 | 23749435 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 25783894 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 2.16e-05 | 2 | 162 | 2 | 3037333 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 21836066 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 11726230 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 2.16e-05 | 2 | 162 | 2 | 6950384 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 2.16e-05 | 2 | 162 | 2 | 8428773 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 24638111 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 6019133 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 2.16e-05 | 2 | 162 | 2 | 21345967 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 24473438 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 22972916 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 2572548 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 27188183 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 2302180 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 10946278 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 20814177 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 12811819 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 2.16e-05 | 2 | 162 | 2 | 18091514 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 29080553 | ||
| Pubmed | A novel human actin-binding protein homologue that binds to platelet glycoprotein Ibalpha. | 2.16e-05 | 2 | 162 | 2 | 9694715 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 2.16e-05 | 2 | 162 | 2 | 25339671 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 17728371 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 6149580 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 6149581 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 12450380 | ||
| Pubmed | Ablation of Ctrp9, Ligand of AdipoR1, and Lower Number of Cone Photoreceptors in Mouse Retina. | 2.16e-05 | 2 | 162 | 2 | 35575905 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 30426302 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 12115608 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 3542363 | ||
| Pubmed | CTRP9 ameliorates cellular senescence via PGC‑1α/AMPK signaling in mesenchymal stem cells. | 2.16e-05 | 2 | 162 | 2 | 29749459 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 2387317 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 3665768 | ||
| Pubmed | CTRP9 induces iNOS expression through JAK2/STAT3 pathway in Raw 264.7 and peritoneal macrophages. | 2.16e-05 | 2 | 162 | 2 | 31837806 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 16908004 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 7365238 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 28978553 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 7391573 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 17971360 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 2.16e-05 | 2 | 162 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 2.16e-05 | 2 | 162 | 2 | 17971229 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 32283037 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 6881182 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 22699679 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 2.16e-05 | 2 | 162 | 2 | 17921792 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 2.16e-05 | 2 | 162 | 2 | 6978711 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 35898513 | ||
| Pubmed | C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure. | 2.16e-05 | 2 | 162 | 2 | 27821723 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 28873507 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 276882 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 2.16e-05 | 2 | 162 | 2 | 6832377 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 3794341 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 22785613 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 35008006 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 32691186 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 2.16e-05 | 2 | 162 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 2.16e-05 | 2 | 162 | 2 | 3902619 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 2.16e-05 | 2 | 162 | 2 | 7373044 | |
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 2.16e-05 | 2 | 162 | 2 | 3696167 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 24030394 | ||
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 2.16e-05 | 2 | 162 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 2.16e-05 | 2 | 162 | 2 | 16098595 | |
| Interaction | KDM1A interactions | FLNB TSHZ3 H3-5 GEMIN5 MECOM ZDBF2 ZNF318 ANKHD1 THOC2 NDUFS1 MSTO1 DENND4C PRDM2 CEP350 ARRB2 TTC23 BUB1 LTF AKAP1 TASOR SMAD9 FBXW7 | 4.00e-06 | 941 | 157 | 22 | int:KDM1A |
| Interaction | IGFBP3 interactions | 7.92e-06 | 61 | 157 | 6 | int:IGFBP3 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.47e-05 | 9 | 103 | 3 | 1234 | |
| GeneFamily | Transferrins | 9.61e-05 | 3 | 103 | 2 | 908 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 9.45e-04 | 34 | 103 | 3 | 487 | |
| GeneFamily | Complement system|Sushi domain containing | 1.12e-03 | 36 | 103 | 3 | 492 | |
| GeneFamily | Olfactory receptors, family 1 | 1.52e-03 | 40 | 103 | 3 | 147 | |
| GeneFamily | UPF1 like RNA helicases | 1.71e-03 | 11 | 103 | 2 | 1169 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.28e-03 | 161 | 103 | 5 | 593 | |
| GeneFamily | Kallikreins | 3.66e-03 | 16 | 103 | 2 | 616 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 4.13e-03 | 17 | 103 | 2 | 1197 | |
| GeneFamily | Endogenous ligands|C1q and TNF related | 4.63e-03 | 18 | 103 | 2 | 1372 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 5.16e-03 | 19 | 103 | 2 | 909 | |
| Coexpression | GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 4.30e-07 | 199 | 160 | 10 | M8380 | |
| Coexpression | GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_UP | 3.92e-06 | 199 | 160 | 9 | M6381 | |
| Coexpression | GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 4.09e-06 | 200 | 160 | 9 | M302 | |
| Coexpression | BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN | 1.80e-05 | 53 | 160 | 5 | M4090 | |
| Coexpression | VEGF_A_UP.V1_DN | 2.57e-05 | 193 | 160 | 8 | M2675 | |
| Coexpression | GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_UP | 2.66e-05 | 194 | 160 | 8 | M6133 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP | 4.68e-05 | 210 | 160 | 8 | MM751 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | HSPG2 FLNB FLT1 ADAMTSL1 FN1 PELI2 MECOM PIK3C2A SETBP1 SMAD9 | 2.45e-09 | 193 | 162 | 10 | 01c2df9206f1527c578e808978e58196c35e72f5 |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | HSPG2 FLNB FLT1 ADAMTSL1 FN1 PELI2 MECOM PIK3C2A SETBP1 SMAD9 | 2.58e-09 | 194 | 162 | 10 | b6cc849fa08599bff9839ef382d190cc964e273e |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.27e-08 | 189 | 162 | 9 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 3.27e-08 | 189 | 162 | 9 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 3.75e-08 | 192 | 162 | 9 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_venous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | HSPG2 FLT1 LINC00305 C1QTNF9B SERTAD4-AS1 C1QTNF9 ANKRD61 CCL23 SMAD9 | 5.09e-08 | 199 | 162 | 9 | d62a2cb81b01ae59969e0b2bbe99c1c9cc96fdaa |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 4.57e-07 | 188 | 162 | 8 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.75e-07 | 189 | 162 | 8 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.95e-07 | 190 | 162 | 8 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.57e-07 | 193 | 162 | 8 | 0ef076417ffe2dd1cbc2c3d1e35c7f8522af143b | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 5.57e-07 | 193 | 162 | 8 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-Plasmablast|Influenza_Severe / Disease, condition lineage and cell class | 6.50e-07 | 197 | 162 | 8 | 9108edafbf5744ed65f556bcbbf819a9b71176a9 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.76e-07 | 198 | 162 | 8 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-06 | 156 | 162 | 7 | 4877aabf647238c0279e497345b6a6d5ee07ef9c | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 156 | 162 | 7 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-06 | 156 | 162 | 7 | 1d681fa17e62815f5d5f90c86be3c248b38e011b | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-06 | 172 | 162 | 7 | 6fcc16f1067672967ecbcdfdc727649ae9891dd9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-06 | 178 | 162 | 7 | 375156ba1c7b8592bf733c75f24968161f7cfa09 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.25e-06 | 179 | 162 | 7 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.41e-06 | 180 | 162 | 7 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.75e-06 | 182 | 162 | 7 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.10e-06 | 184 | 162 | 7 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.28e-06 | 185 | 162 | 7 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 5.67e-06 | 187 | 162 | 7 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.51e-06 | 191 | 162 | 7 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 6.51e-06 | 191 | 162 | 7 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 6.74e-06 | 192 | 162 | 7 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 6.97e-06 | 193 | 162 | 7 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.24e-06 | 198 | 162 | 7 | 0a4626b51ba8b52acbaf616f0ced850079cd7149 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.24e-06 | 198 | 162 | 7 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.24e-06 | 198 | 162 | 7 | d1f54ed3ef5e05ebda7da999e172d168dc6802cd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.24e-06 | 198 | 162 | 7 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.24e-06 | 198 | 162 | 7 | 8d6b0b9da7c1e64155cbcbb04ad38d129a29030c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.24e-06 | 198 | 162 | 7 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.79e-06 | 200 | 162 | 7 | e6d36be0c4c569e27303bb4e4f34cd2187e9759d | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Macrophages|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.79e-06 | 200 | 162 | 7 | c0c51719cf81512c50bfcc2fed883c867e522d2a | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.79e-06 | 200 | 162 | 7 | 758840c31f2ddd7ccf7bf13252ebb48d33e89479 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.79e-06 | 200 | 162 | 7 | 27507c4b41d45c7cc50e4993169c0302be22ee34 | |
| ToppCell | medial-Endothelial-Vein-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.79e-06 | 200 | 162 | 7 | 3f689029f5bc7db0af50a405f1e252aeec529077 | |
| ToppCell | medial-Endothelial-Vein|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.79e-06 | 200 | 162 | 7 | 1163e5f6dfb304c94bf8885629350454f4b6bee8 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.79e-06 | 200 | 162 | 7 | c55efd997392e99068b673542f56f1a209c5a6c8 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.79e-06 | 200 | 162 | 7 | b65fb8d378abd91cdabf5faac5f4b90d527f8c44 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.79e-06 | 200 | 162 | 7 | 2cb6e35add34b9dc564ebcf5d3cbc761325ca9f4 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Bronchial_vessel|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.79e-06 | 200 | 162 | 7 | a18817d36b2b30a32e1513d36174bf98dfea2a92 | |
| ToppCell | medial-2-Endothelial-Vein|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.79e-06 | 200 | 162 | 7 | 49da4e3ff10262a492c2cf566a7f2e35e418bfda | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.79e-06 | 200 | 162 | 7 | 71979bbcc035d5b8882f1502b5a8ef248aaba45a | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.79e-06 | 200 | 162 | 7 | c37fe06a94e5779c56e01389869bb432d3bbaebc | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-05 | 157 | 162 | 6 | dd08dc19d434e94a194076c462ee273c682abf55 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-05 | 157 | 162 | 6 | 70fd6c46db4250c7de5c4686a9500689402737f6 | |
| ToppCell | Severe-B_naive-5|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.40e-05 | 157 | 162 | 6 | a57ee4a6febdff3ee3d1645836695e6e7c055cf8 | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 3.28e-05 | 166 | 162 | 6 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-05 | 168 | 162 | 6 | d2b91f2adc95dcfa623f8d7ca2df1c6f884da988 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 170 | 162 | 6 | 50c6c571591aa4b218caefe5778c570c809f567e | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 170 | 162 | 6 | 8fe32dcf924d5f6665f7febbc9647d96b1e96f06 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_ventral_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.74e-05 | 170 | 162 | 6 | 73601c873b177d5d134618d8e228c51381119f7d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 170 | 162 | 6 | 3232db50b1a40f861e981a1b9c9073b81af9f832 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-05 | 172 | 162 | 6 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-05 | 172 | 162 | 6 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 4.00e-05 | 172 | 162 | 6 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.13e-05 | 173 | 162 | 6 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.13e-05 | 173 | 162 | 6 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 4.26e-05 | 174 | 162 | 6 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-05 | 174 | 162 | 6 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.26e-05 | 174 | 162 | 6 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.26e-05 | 174 | 162 | 6 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.26e-05 | 174 | 162 | 6 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | severe_influenza-Plasmablast|World / disease group, cell group and cell class (v2) | 4.40e-05 | 175 | 162 | 6 | e6d6c44510d5dc4eb0bae820125e42366f7a4e74 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.40e-05 | 175 | 162 | 6 | 73f25bd54309aed1480ddc44bdab518b17e71f92 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.69e-05 | 177 | 162 | 6 | 9b02fd91c110b405eba6cb74ceb90b1286535973 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 178 | 162 | 6 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 178 | 162 | 6 | 200308e109abb7e6f8816a6f8cce6d56862d4098 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-05 | 179 | 162 | 6 | 8f9e538c822940785130297712b75131812a4603 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.15e-05 | 180 | 162 | 6 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-05 | 182 | 162 | 6 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.47e-05 | 182 | 162 | 6 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 5.47e-05 | 182 | 162 | 6 | a035d45fd512bee8dac38eb387dbf39f5a8a1fed | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 5.64e-05 | 183 | 162 | 6 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.81e-05 | 184 | 162 | 6 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.81e-05 | 184 | 162 | 6 | 54e5b63f55b8d6eccad53d389ea9c78f991e1414 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.81e-05 | 184 | 162 | 6 | 7b5678718719020b52e7c2a7bd9797987defd7ff | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 5.99e-05 | 185 | 162 | 6 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pdgfa_(Mural.Rgs5Acta2.Pdgfa)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.09e-05 | 114 | 162 | 5 | 2cc5d2da5573650c5232a01e2d2128082c4bffcb | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pdgfa_(Mural.Rgs5Acta2.Pdgfa)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.09e-05 | 114 | 162 | 5 | fceb7cc590a47380145fc0d854c9f2350dbb0a59 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.17e-05 | 186 | 162 | 6 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-05 | 186 | 162 | 6 | bcb3ac9f9b51346e0a2b0bda96d149b3c11f7883 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.17e-05 | 186 | 162 | 6 | ffbc78058be8f0dc2e0335cc4c3195a636d17721 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.17e-05 | 186 | 162 | 6 | ed924852cd7132c8f6703522037dc22bd2c83193 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.36e-05 | 187 | 162 | 6 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.36e-05 | 187 | 162 | 6 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 6.36e-05 | 187 | 162 | 6 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 6.55e-05 | 188 | 162 | 6 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 6.55e-05 | 188 | 162 | 6 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 189 | 162 | 6 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 189 | 162 | 6 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 189 | 162 | 6 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Control / Disease state, Lineage and Cell class | 6.74e-05 | 189 | 162 | 6 | 937e876122bc4b94372a4104e9c1a9068c232018 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 189 | 162 | 6 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 190 | 162 | 6 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.94e-05 | 190 | 162 | 6 | 3b9abc25b17e7295356ded57ff2ca519fa9f2686 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.94e-05 | 190 | 162 | 6 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| Disease | skin disease (implicated_via_orthology) | 8.30e-05 | 3 | 156 | 2 | DOID:37 (implicated_via_orthology) | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 8.30e-05 | 3 | 156 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 8.30e-05 | 3 | 156 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | FLNC FN1 WNK1 AXIN2 FAT1 SACS SETBP1 BUB1 ETAA1 OR1E2 CNTN1 SMAD9 FBXW7 | 9.70e-05 | 702 | 156 | 13 | C0009402 |
| Disease | glomerulonephritis (is_marker_for) | 1.32e-04 | 19 | 156 | 3 | DOID:2921 (is_marker_for) | |
| Disease | endometrial adenocarcinoma (is_implicated_in) | 5.73e-04 | 7 | 156 | 2 | DOID:2870 (is_implicated_in) | |
| Disease | Complement deficiency disease | 7.04e-04 | 33 | 156 | 3 | C0272242 | |
| Disease | beta-defensin 119 measurement | 7.62e-04 | 8 | 156 | 2 | EFO_0801419 | |
| Disease | Adenocarcinoma of lung (disorder) | 8.21e-04 | 206 | 156 | 6 | C0152013 | |
| Disease | 1-ribosyl-imidazoleacetate measurement | 9.76e-04 | 9 | 156 | 2 | EFO_0800034 | |
| Disease | hyperglycemia (is_implicated_in) | 1.22e-03 | 10 | 156 | 2 | DOID:4195 (is_implicated_in) | |
| Disease | membranoproliferative glomerulonephritis (biomarker_via_orthology) | 1.22e-03 | 10 | 156 | 2 | DOID:2920 (biomarker_via_orthology) | |
| Disease | aortic stenosis, aortic valve calcification | 1.43e-03 | 42 | 156 | 3 | EFO_0000266, EFO_0005239 | |
| Disease | Aortic Valve Insufficiency | 1.48e-03 | 11 | 156 | 2 | C0003504 | |
| Disease | uric acid measurement | CLDN14 SESTD1 C1QTNF9B MECOM ZNF318 CPS1 SETBP1 TM4SF4 MAP4K2 QSOX2 | 1.57e-03 | 610 | 156 | 10 | EFO_0004761 |
| Disease | Malignant neoplasm of breast | FLNB FLT1 KLK10 ERCC3 FN1 ACO2 MECOM ZNF318 PRC1 WNK1 SLC22A18 SETBP1 DLEC1 FBXW7 | 1.74e-03 | 1074 | 156 | 14 | C0006142 |
| Disease | urate measurement, bone density | CLDN14 MINPP1 DNAH1 FSIP2 C9orf152 PLXNC1 A2ML1 C1QTNF9 C2 CD302 | 1.75e-03 | 619 | 156 | 10 | EFO_0003923, EFO_0004531 |
| Disease | C-C motif chemokine 16 measurement | 1.77e-03 | 12 | 156 | 2 | EFO_0008044 | |
| Disease | peptide measurement | 2.72e-03 | 109 | 156 | 4 | EFO_0010520 | |
| Disease | Spondyloepiphyseal Dysplasia | 3.17e-03 | 16 | 156 | 2 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 3.17e-03 | 16 | 156 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 3.17e-03 | 16 | 156 | 2 | C4551479 | |
| Disease | central nervous system disease (implicated_via_orthology) | 3.17e-03 | 16 | 156 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | preeclampsia, parental genotype effect measurement | 3.17e-03 | 16 | 156 | 2 | EFO_0000668, EFO_0005939 | |
| Disease | Schwartz-Jampel Syndrome | 3.17e-03 | 16 | 156 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 3.17e-03 | 16 | 156 | 2 | C0025237 | |
| Disease | Van Buchem disease | 3.59e-03 | 17 | 156 | 2 | C0432272 | |
| Disease | diastolic blood pressure, alcohol drinking | 3.62e-03 | 118 | 156 | 4 | EFO_0004329, EFO_0006336 | |
| Disease | Myeloid Leukemia | 4.02e-03 | 18 | 156 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 4.02e-03 | 18 | 156 | 2 | C0023466 | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 4.36e-03 | 62 | 156 | 3 | DOID:9074 (is_implicated_in) | |
| Disease | osteochondrodysplasia (is_implicated_in) | 4.48e-03 | 19 | 156 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Osteochondrodysplasias | 4.48e-03 | 19 | 156 | 2 | C0029422 | |
| Disease | Dyschondroplasias | 4.48e-03 | 19 | 156 | 2 | C0013366 | |
| Disease | systolic blood pressure, alcohol drinking | 4.83e-03 | 128 | 156 | 4 | EFO_0004329, EFO_0006335 | |
| Disease | Multiple Epiphyseal Dysplasia | 4.96e-03 | 20 | 156 | 2 | C0026760 | |
| Disease | citrulline measurement | 4.96e-03 | 20 | 156 | 2 | EFO_0009777 | |
| Disease | PR interval | 4.97e-03 | 495 | 156 | 8 | EFO_0004462 | |
| Disease | magnesium measurement | 5.20e-03 | 66 | 156 | 3 | EFO_0004845 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PALELSKASVTKCSI | 1046 | Q13075 | |
| HGLKCKSQFTITPGS | 406 | Q99798 | |
| SPKGVLFSSKSAEVC | 151 | Q92667 | |
| KAGLKCGPITSTTRF | 86 | Q86XL3 | |
| CGPITSTTRFIFEKK | 91 | Q86XL3 | |
| SECSKPGVIFLTKKG | 76 | P55773 | |
| DSCKFGTSVSNIIKP | 566 | Q4VNC0 | |
| SAQVATRFKLKSPCS | 391 | Q8IYX3 | |
| FPKGTIFTAKCETSG | 956 | O43683 | |
| LSLSKTKGLCVATPV | 811 | P0C0L5 | |
| SKTEGSVCLFKQAPS | 91 | Q5JQC9 | |
| STPKGACATSVKVAI | 31 | P51857 | |
| KITSRAAAPVCSSKT | 176 | Q8IUR6 | |
| KVAKVTPGSTCAVFG | 186 | P00326 | |
| STKPKRTEGKFCATF | 951 | P51816 | |
| SSVEGTLCKTAIPYK | 146 | Q8IX05 | |
| SLLCPKGKVASESVS | 916 | A8K2U0 | |
| PAASGCKQTSTKRKV | 311 | Q14094 | |
| CKLSPTVVGLSSKTL | 241 | Q9Y2T1 | |
| NTPLKLAVCTASSKA | 236 | A6NGH8 | |
| SVDPKKVKTLVFCSG | 796 | Q96HY7 | |
| GTRVFKKSSPNCKLT | 6 | P32121 | |
| DAPSGKTVSVAVKCL | 146 | Q07912 | |
| ESGLKFSTQCPLSIK | 191 | Q5JTZ5 | |
| LIGKPSGKSKDCVFT | 116 | O60258 | |
| TIKGSKVQVSFCAPG | 296 | Q9HCJ3 | |
| GADVTFICTAKSKSP | 1786 | P98160 | |
| KAFLEKLGVSSVPSC | 246 | Q6ZRP7 | |
| SKSGQVVFAPKSICL | 286 | Q9ULD8 | |
| FALSTKIPDTKGCLQ | 586 | Q12851 | |
| PECGKTFATSSGLKQ | 351 | Q03112 | |
| KGKPVSLSSTCYVEV | 1006 | Q14517 | |
| VFFTTPPCSALKGKS | 516 | P23352 | |
| LSFIDLGACSVTSPK | 66 | O95013 | |
| FKKLRETACSSPGSI | 236 | O43187 | |
| GKATVTIESCAPTLF | 366 | Q8NBH2 | |
| KLNSSLIGSKFCPTE | 326 | Q9Y234 | |
| QTPGATRSLSKAVCK | 71 | P06681 | |
| PSGLTKLCLAKTAIS | 301 | Q8ND23 | |
| GACSKPAKVAVTKTV | 6 | Q5CZC0 | |
| LSFATPTLKCSIADK | 2111 | Q5CZC0 | |
| KVSKKTGPRCSTAIA | 86 | Q9BW19 | |
| TCQKLKASGISTPVS | 1571 | Q8N6G6 | |
| LATKAARKSTPSTCG | 21 | Q6NXT2 | |
| KCLATGPGIASTVKT | 1616 | O75369 | |
| KTAGKGKVTCTVLTP | 1641 | O75369 | |
| CGFLAPSLKSSKVRT | 806 | O60486 | |
| GVLDLSTKKSPCAGS | 81 | Q96JN0 | |
| FSSLLGRAVSPKSVC | 21 | Q8TE12 | |
| IKSCSFFSSNAVPLK | 1106 | O00443 | |
| SFCGKKVVTAGAIIP | 361 | Q9BUK6 | |
| KAAGEGKVTCTVSTP | 1671 | Q14315 | |
| FKTTVCSITKRPDFS | 106 | P31512 | |
| FETLVSGIKKCPSFL | 106 | O60774 | |
| VVDPKTKNCTTLAGT | 501 | Q8NBF2 | |
| FSKVCALPTVSGKHQ | 286 | P30307 | |
| PSVAKGKSRAKISCT | 166 | Q9NY74 | |
| AKVCGAASESPSVKS | 66 | Q96HP4 | |
| DPSAVLGKCSSSIKA | 291 | Q6GPH6 | |
| GDCCSSTLSSKKVIP | 1756 | Q9BXP8 | |
| STLSSKKVIPFAADC | 1761 | Q9BXP8 | |
| KSAFTVGLTVLSKFP | 201 | P0C862 | |
| FQPATIAKVSKACTS | 3021 | Q9P2D7 | |
| KNVVSGKTSACFEPS | 751 | P31327 | |
| SKPISGLTGAKFICF | 226 | Q5TD97 | |
| KEAVSSPAVTSCVGK | 441 | Q6TFL4 | |
| GVCKDSKDLFVPTSS | 61 | Q6ZS62 | |
| RCAKGTPAKTTFAIL | 106 | O95500 | |
| TSVVIVGKISFCPKD | 561 | O75460 | |
| KTFGKSILCSKEVPA | 441 | O00311 | |
| CLGTAVPSTGASKSK | 16 | P02751 | |
| KISKPIKFELSGCTS | 261 | P29279 | |
| QPSGLSATLTKVKCA | 46 | Q7Z4B0 | |
| CFVSSPSITKSVFSK | 211 | Q12860 | |
| KPCKVSEYTSTTGLV | 186 | Q969H0 | |
| KSAFTVGLTVLSKFP | 201 | B2RNN3 | |
| SISIPTKLLGCASKG | 2946 | Q5VT06 | |
| DAKILTAALTCPKTS | 1076 | Q5VZ89 | |
| GCFLKDSVTGTLPKV | 76 | P03952 | |
| AKDKPIGCSVAISTY | 396 | P19447 | |
| TSSKVSPELAGSCKF | 5766 | Q8NDH2 | |
| KGKLGVCFDVPTASV | 676 | Q9NR30 | |
| LGSLGKVDPLCSSKT | 211 | Q7Z2K8 | |
| ISLPGCSKLTFSCEK | 226 | Q9Y238 | |
| VFLTSIFVKAGCSPS | 921 | P51530 | |
| ILGTAISNYCKKTPS | 351 | Q9NZJ4 | |
| TLPAAKGSTVKLECF | 236 | Q9P232 | |
| LSLSKTKGLCVATPV | 811 | P0C0L4 | |
| PQTFTTAIRCTKCGK | 1326 | Q13029 | |
| KVPSSKGICKAFSTC | 236 | P47887 | |
| GSLSIIKSKIPTYCS | 231 | Q8N7B6 | |
| QVPSTKGVLKAFSTC | 226 | Q9P1Q5 | |
| IVSSILKVPSSKGIC | 221 | P30953 | |
| LKVPSSKGICKAFST | 226 | P30953 | |
| PKKTISFLGCSVQLF | 86 | Q9GZK4 | |
| IPTTKGQSKAFSTCF | 226 | Q96R54 | |
| LSFIDLGACSVTSPK | 66 | Q6IEY1 | |
| LSTSAPKGLTKVNIC | 86 | Q9NP80 | |
| QLGLGSKSAISKPTC | 66 | Q92834 | |
| SSKGTPSKFVIPVSC | 101 | Q9HBJ0 | |
| CGSSPFTTDKETVLK | 411 | Q9NUJ3 | |
| QTSCVALKKGSSTFP | 276 | Q8NEY4 | |
| SPLALLAATCSKIGT | 46 | Q02446 | |
| ICTDPLVSKISFTGS | 271 | P51649 | |
| CSIINSGKIDVKTPF | 191 | P45877 | |
| YVAGITNLKKCSTSP | 686 | P02788 | |
| GQKVSATASIPFSCK | 106 | Q5TG53 | |
| TCTIVGPTKRDSKFI | 141 | Q5JUQ0 | |
| VGLSKSPKGCVRTTA | 11 | P28331 | |
| VFTTCPKRESKSGAL | 341 | Q5QGS0 | |
| VISTPQASKAISCKG | 61 | Q9HAT8 | |
| SVLFTLFCVPETKGK | 451 | Q9NY64 | |
| VCFSPDGKKIATIGS | 286 | Q96BP3 | |
| VAASTCSGKKTPRTG | 526 | O43663 | |
| SVTKSKCPSYVGITG | 141 | O95707 | |
| KCAKLPTTAFTRSSE | 491 | Q7Z333 | |
| AKPTKADITLSGCAS | 91 | Q6Q0C1 | |
| LGSTPDAKLDKTCIS | 551 | Q8NCN4 | |
| VLSFTCIPASTKGAK | 196 | Q96BI1 | |
| ATVCKIPSGCSLKVF | 371 | O15198 | |
| LSIPSEKCKARGFTV | 51 | Q86VW0 | |
| TLKKLPCVSFAGVDS | 1296 | Q9UK61 | |
| VSEFVASKPGTCVKV | 211 | Q969K4 | |
| SLCSPSSVAVIEAKK | 326 | O15204 | |
| SSVKSVPENLLKCFG | 156 | Q13155 | |
| SSVRKQLFACVPKTS | 1956 | Q8IWZ3 | |
| KKICTERLGPSLSSS | 186 | Q9C0C6 | |
| SQCSKPSVIFLTKRG | 56 | P16619 | |
| LLKYCSVATSLKAPG | 11 | Q9NQ32 | |
| ICFVKPTSSMTIKTG | 86 | Q99816 | |
| QKGYASCATASKVPI | 1461 | O75094 | |
| STIKSSVSTKPHGCL | 131 | Q495C1 | |
| LNKGIKTFFTSPCTE | 331 | Q9H6R6 | |
| VCKLCGKTFPRTSSL | 201 | Q8NEP9 | |
| CGVKAVNKASSTTPK | 1236 | Q8NI27 | |
| SDGPSVACVKKASYL | 51 | P02787 | |
| SKFLCSKATTPVNID | 771 | O14924 | |
| FTCSFDLAIKGVKSP | 286 | Q9UNW1 | |
| ISAKAATCFAEKLPS | 161 | O95210 | |
| KKCTIESIFPGFASQ | 81 | Q92800 | |
| CTPVSSGFEKSKVTI | 806 | Q8TEQ6 | |
| KIGTVEFPASCTKVL | 1986 | Q9HCK1 | |
| SGSSKDSCLNVKTPI | 156 | O00534 | |
| LCELTVTGHFKTPSK | 771 | Q8TEA7 | |
| SCLGPKKLSLTSEAA | 321 | Q86YV5 | |
| KSDKGCSLGSVLLSP | 796 | Q63HK5 | |
| TESCKPLNIAFKSSV | 331 | Q658L1 | |
| CPKPSVLSSKISSFG | 1311 | Q96JG9 | |
| ITPQSFLTGEKSCKD | 231 | Q5TYW1 | |
| KGTECVKSTPVTSAV | 521 | Q96KR1 | |
| ATKGLCLEKLPISSS | 146 | Q86TV6 | |
| SKAKVAFCTSIPQDT | 421 | Q5W5X9 | |
| KPSLGSGSCSALIKL | 236 | Q8NHP8 | |
| PFKCTVCKRGFSSTS | 221 | Q2M1K9 | |
| ITKVACIPKSSQFFS | 106 | Q8NA23 | |
| KCDNIFITGPTGSVK | 351 | Q9H4A3 | |
| FASVGSKSSVVPCEL | 421 | Q9Y6M5 | |
| SKLIFTKGKSPTVVC | 951 | Q5VYS8 | |
| VVQASAFGIKKSPTC | 841 | P17948 | |
| AFGIKKSPTCRTVAV | 846 | P17948 | |
| ILSCSSSVALKAKAP | 681 | Q9Y6X0 | |
| VVIKLSPQACSFTKA | 1851 | Q5VUA4 | |
| SFIISAISINKGPKC | 106 | P48230 | |
| SECGKAFSQKSPLII | 356 | Q96RE9 | |
| TKQPSILSKFCSLGK | 346 | O94782 | |
| SFSLPTCRISESVKK | 471 | O43264 | |
| KGFKCPSTLTTHKVI | 516 | O75373 | |
| KGLTCSSITILSPKE | 186 | O43240 | |
| KSPDLVSFVQTLCKG | 161 | Q13562 |